Literature DB >> 26246063

[Loperamide for acute infectious diarrhoea].

Joeri A J Douma1, Yvo M Smulders.   

Abstract

Many physicians are resistant to the idea of prescribing loperamide for acute infectious traveller's diarrhoea and community-acquired diarrhoea because of the fear of possible adverse effects. Large randomized trials with loperamide, either alone or as an adjunct to antibiotic treatment, have in fact revealed positive rather than negative effects. International guidelines now often support the use of loperamide for the treatment of infectious diarrhoea without dysentery. There seems to be no reason to systematically avoid loperamide in patients with dysentery, but caution is advised. Loperamide can be used as monotherapy or as an adjunct to antibiotic treatment in immunocompetent adults with acute infectious traveller's diarrhoea or community-acquired diarrhoea without severe comorbidities. This can reduce both the frequency of diarrhoea and the time until the diarrhoea stops without the risk of severe complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26246063

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

Review 1.  A Comprehensive Comparison of the Efficacy and Tolerability of Racecadotril with Other Treatments of Acute Diarrhea in Adults.

Authors:  Wolfgang Fischbach; Viola Andresen; Marion Eberlin; Tobias Mueck; Peter Layer
Journal:  Front Med (Lausanne)       Date:  2016-10-14

2.  Survey of potentially inappropriate prescriptions for common cold symptoms in Japan: A cross-sectional study.

Authors:  Yasuhisa Nakano; Takashi Watari; Kazuya Adachi; Kenji Watanabe; Kazuya Otsuki; Yu Amano; Yuji Takaki; Kazumichi Onigata
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.